摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2R,6S)-2,6-dimethyl-1-(5-phenoxypentyl)piperidine

中文名称
——
中文别名
——
英文名称
(2R,6S)-2,6-dimethyl-1-(5-phenoxypentyl)piperidine
英文别名
——
(2R,6S)-2,6-dimethyl-1-(5-phenoxypentyl)piperidine化学式
CAS
——
化学式
C18H29NO
mdl
——
分子量
275.4
InChiKey
KYEVBDULERXENV-CALCHBBNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    20
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    12.5
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • Non-imidazole aryloxy (or arylthio) alkylamines as histamine H3-receptor antagonists and their therapeutic applications
    申请人:SOCIETE CIVILE BIOPROJET
    公开号:EP0978512A1
    公开(公告)日:2000-02-09
    Compounds of formula (I): and their use for preparing medicaments acting as antagonists at the H3-receptors of histamine.
    式(I)的化合物及其用于制备作为组胺H3受体拮抗剂的药物。
  • Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
    申请人:——
    公开号:US20040220225A1
    公开(公告)日:2004-11-04
    Use of a compound of formula (A), wherein: 1 W is a residue which imparts antagonistic and/or agonistic activity at histamine H 3 -receptors when attached to an imidazole ring in 4(5) position; R 1 and R 2 may be identical or different and represent each independently a lower alkyl or cycloalkyl, or taken together with the nitrogen atom to which they are attached, a saturated nitrogen-containing ring (i) as defined, a non-aromatic unsaturated nitrogen-containing ring (ii) as defined, a morpholino group, or a N-substituted piperazino group as defined for preparing medicaments acting as antagonists and/or agonists at the H 3 -receptors of histamine.
    使用式(A)的化合物,其中:1W是一个残基,当附加在咪唑环的4(5)位时,赋予组合物在组胺H3受体上的拮抗和/或激动活性;R1和R2可以相同也可以不同,分别独立地表示较低的烷基或环烷基,或者与它们所连接的原子一起,表示饱和的含氮环(i)、非芳香性不饱和含氮环(ii)、吗啡环或N-取代哌嗪环,用于制备在组胺H3受体上作为拮抗剂和/或激动剂的药物。
  • Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications
    申请人:Schwartz Jean-Charles
    公开号:US20060247223A1
    公开(公告)日:2006-11-02
    Use of a compound of formula (A), wherein: W is a residue which imparts antagonistic and/or agonistic activity at histamine H 3 -receptors when attached to an imidazole ring in 4(5) position; R 1 and R 2 may be identical or different and represent each independently a lower alkyl or cycloalkyl, or taken together with the nitrogen atom to which they are attached, a saturated nitrogen-containing ring (i) as defined, a non-aromatic unsaturated nitrogen-containing ring (ii) as defined, a morpholino group, or a N-substituted piperazino group as defined for preparing medicaments acting as antagonists and/or agonists at the H 3 -receptors of histamine.
    使用公式(A)中的化合物,其中: W是一个残留物,当附加到咪唑环的4(5)位时,赋予组织胺H3受体的拮抗和/或激动活性; R1和R2可以相同也可以不同,并且独立地表示较低的烷基或环烷基,或者与它们附着的原子一起,表示饱和的含氮环(i)如定义,非芳香性不饱和含氮环(ii)如定义,吗啉基或N-取代的哌嗪基,如定义,用于制备作为组织胺H3受体的拮抗剂和/或激动剂的药物。
  • NON-IMIDAZOLE ALKYLAMINES AS HISTAMINE H3-RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS
    申请人:SCHWARTZ Jean-Charles
    公开号:US20110281844A1
    公开(公告)日:2011-11-17
    Use of a compound of formula (A), wherein: W is a residue which imparts antagonistic and/or agonistic activity at histamine H 3 -receptors when attached to an imidazole ring in 4(5) position; R 1 and R 2 may be identical or different and represent each independently a lower alkyl or cycloalkyl, or taken together with the nitrogen atom to which they are attached, a saturated nitrogen-containing ring (i) as defined, a non-aromatic unsaturated nitrogen-containing ring (ii) as defined, a morpholino group, or a N-substituted piperazino group as defined for preparing medicaments acting as antagonists and/or agonists at the H 3 -receptors of histamine.
    使用公式(A)中的化合物,其中: W是一个残基,当连接到咪唑环的4(5)位置时,赋予组合物在组胺H3受体上的拮抗和/或激动活性;R1和R2可能相同也可能不同,且分别独立地代表较低的烷基或环烷基,或者与它们连接的原子一起,代表饱和的含氮环(i),如所定义,非芳香性不饱和含氮环(ii),如所定义,吗啡啶基团,或所定义的N-取代哌嗪基团,以制备在组胺H3受体上作为拮抗剂和/或激动剂的药物。
  • Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
    申请人:SOCIETE CIVILE BIOPROJET
    公开号:EP0982300A2
    公开(公告)日:2000-03-01
    Compounds of formula (A): wherein: ― W is a residue which imparts antagonistic and/or agonistic activity at histamine H3-receptors when attached to an imidazole ring in 4(5) position. ― R1 and R2 may be identical or different and represent each independently a lower alkyl or cycloalkyl, or taken together with the nitrogen atom to which they are attached, a saturated nitrogen-containing ring (i) as defined, a non-aromatic unsaturated nitrogen-containing ring (ii) as defined, a morpholino group, or a N-substituted piperazino group as defined. Compounds (A) are useful for preparing medicaments acting as antagonists and/or agonists at the H3-receptors of histamine.
    式(A)化合物: 其中 - W 是一个残基,当它连接到 4(5) 位的咪唑环上时,可对组胺 H3 受体产生拮抗和/或激动活性。 - R1 和 R2 可以相同或不同,各自独立地代表 低级烷基或环烷基,或与所连接的原子一起、 定义的饱和含氮环 (i) 定义的非芳族不饱和含氮环 (ii) 吗啉基团,或 定义的 N-取代的哌嗪基团。 化合物(A)可用于制备作为组胺 H3 受体拮抗剂和/或激动剂的药物。
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯